HQY Stock Overview
Provides technology-enabled services platforms to consumers and employers in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
HealthEquity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$96.84 |
| 52 Week High | US$105.82 |
| 52 Week Low | US$65.01 |
| Beta | 0.53 |
| 1 Month Change | -4.63% |
| 3 Month Change | 20.64% |
| 1 Year Change | 46.06% |
| 3 Year Change | 106.75% |
| 5 Year Change | 34.20% |
| Change since IPO | 450.23% |
Recent News & Updates
Recent updates
HealthEquity's (NASDAQ:HQY) Returns On Capital Not Reflecting Well On The Business
Dec 04
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 20HealthEquity: High Marks For Recent Profit Growth
Nov 20We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt
Oct 31Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult
Aug 30HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy
Aug 27Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Jul 13We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation
Jun 21Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jun 07HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore
Jun 04HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind
May 29Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?
May 03Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues
Apr 11HealthEquity: Multiple Compression Has Finally Made It A Buy
Mar 21HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M
Sep 06HealthEquity: Asymmetry In Valuation Continues To Widen
Aug 25HealthEquity COO steps down, CEO to assume his responsibilities
Aug 02Shareholder Returns
| HQY | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 1.8% | -0.4% | -1.1% |
| 1Y | 46.1% | -10.3% | 22.4% |
Return vs Industry: HQY exceeded the US Healthcare industry which returned -9.7% over the past year.
Return vs Market: HQY exceeded the US Market which returned 23.7% over the past year.
Price Volatility
| HQY volatility | |
|---|---|
| HQY Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HQY has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: HQY's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 3,138 | Jon Kessler | www.healthequity.com |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool.
HealthEquity, Inc. Fundamentals Summary
| HQY fundamental statistics | |
|---|---|
| Market cap | US$8.35b |
| Earnings (TTM) | US$96.70m |
| Revenue (TTM) | US$1.15b |
86.8x
P/E Ratio7.3x
P/S RatioIs HQY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HQY income statement (TTM) | |
|---|---|
| Revenue | US$1.15b |
| Cost of Revenue | US$398.81m |
| Gross Profit | US$751.54m |
| Other Expenses | US$654.83m |
| Earnings | US$96.70m |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.12 |
| Gross Margin | 65.33% |
| Net Profit Margin | 8.41% |
| Debt/Equity Ratio | 50.9% |
How did HQY perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 02:21 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HealthEquity, Inc. is covered by 23 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mark Marcon | Baird |
| Ishan Majumdar | Baptista Research |
| Alexander Paris | Barrington Research Associates, Inc. |